TScan Therapeutics Announces Upcoming Presentations at the
WALTHAM, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
Source: globenewswire.com
📰 Friday Posters News
Friday Posters News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Friday Posters. Real-time updates on events, politics, business and more.
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
WALTHAM, Mass., April 22, 2024 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment...
Source: marketscreener.com
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
CAMBRIDGE, Mass., April 22, 2024 -- Editas Medicine, Inc. , a clinical-stage gene editing company, today announced that three abstracts have been accepted for presentation, including one oral...
United States United Kingdom Lindac Burkly Broad Institute Cas Harvard University Cas Editas Medicine Inc
Source: marketscreener.com
GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) ...
– Two accepted abstracts highlight innovative methods for gene expression regulation –
United States South San Francisco Eric Blair Kelli Perkins American Society Of Gene Advanced Therapies
Source: eagletribune.com